IL22 and clostridium difficile infection: In line with these findings, PGRN-treated mice lacking IL-22 showed increased CDI-associated tissue pathology (Figure 6e), and PGRN-treated IL-22 KO mice had increased gut permeability and reduced protein expression of Occludin in the colon tissues compared with PGRN-treated WT mice (Figure 6f, g).